SCHEDULE 13D/A: Saba Capital Reduces Stake in Nuveen New Jersey Quality Municipal Income Fund to 7.11%

Sentiment:

Beneficial Ownership Amendment


Saba Capital Management, L.P. and its affiliates have filed an Amendment No. 18 to their Schedule 13D, disclosing a reduction in their beneficial ownership of Nuveen New Jersey Quality Municipal Income Fund to 7.11% through open market sales.

Summary

  • Saba Capital Management, L.P., Saba Capital Management GP, LLC, and Boaz R. Weinstein (collectively, the "Reporting Persons") have filed an Amendment No. 18 to their Schedule 13D.
  • The Reporting Persons collectively beneficially own 2,930,643 common shares of Nuveen New Jersey Quality Municipal Income Fund, representing 7.11% of the outstanding common stock.
  • This percentage is calculated based on 41,232,935 shares of common stock outstanding as of August 31, 2024, as disclosed in the company's N-CSR filed on November 8, 2024.
  • The funds used for the initial acquisition of common shares were derived from subscription proceeds from investors, capital appreciation, and margin account borrowings.
  • Approximately $33,234,159 was paid to acquire the common shares reported.
  • Between April 22, 2025, and May 2, 2025, Saba Capital effectuated multiple open market sales of common shares, totaling 421,442 shares.
  • Sale prices ranged from $11.23 to $11.44 per share during this period.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to a significant institutional investor reducing its stake, which could be interpreted as a lack of confidence or a strategic reallocation away from the fund. However, it's primarily a disclosure of activity rather than a negative operational report from the issuer.

Negatives

  • A significant institutional investor, Saba Capital, has reduced its stake in the Nuveen New Jersey Quality Municipal Income Fund by selling 421,442 shares in the open market between April 22, 2025, and May 2, 2025.
  • The reduction in ownership from a large holder could be perceived negatively by other investors, potentially signaling a change in investment thesis or a move to reallocate capital.

Risks

  • The document does not explicitly detail risks for the issuer, but the reduction in a significant shareholder's stake could imply a perceived risk by the selling party or could lead to increased selling pressure on the stock.

Future Outlook

The document does not contain any forward-looking statements or guidance regarding the issuer's future performance or strategic direction. It solely focuses on the beneficial ownership and transaction activities of the Reporting Persons.

Industry Context

This filing reflects a change in a significant institutional investor's position in a municipal income fund. While specific industry trends are not detailed, such filings are common for active investors adjusting their portfolio allocations within the closed-end fund or fixed-income sectors.

Comparison to Industry Standards

  • This Schedule 13D/A filing is a standard regulatory disclosure for investors acquiring or changing a significant stake (over 5%) in a public company, aligning with SEC requirements for transparency in beneficial ownership.
  • The reported beneficial ownership of 7.11% by Saba Capital is a substantial stake, indicating a continued, albeit reduced, interest in the fund, which is typical for activist or value-oriented funds in the closed-end fund space.

Legal Proceedings

  • The Reporting Persons (Saba Capital Management, L.P., Saba Capital Management GP, LLC, and Boaz R. Weinstein) have not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) during the last five years.
  • The Reporting Persons have not been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction that resulted in a judgment, decree, or final order enjoining future violations of, prohibiting, or mandating activities subject to Federal or State securities laws, or finding any violation with respect to such laws, during the last five years.

Stakeholder Impact

  • Shareholders: The reduction in Saba Capital's stake might lead to concerns about the fund's future performance or management, potentially influencing other investors' decisions and the fund's share price.
  • Creditors: No direct impact is indicated, as the filing pertains to equity ownership and not the fund's debt obligations.

Key Dates

DateDescription
2015-11-16Date of power of attorney for signature, incorporated by reference to Exhibit 2 of Schedule 13G filed on December 28, 2015.
2024-08-31Date as of which 41,232,935 shares of common stock were outstanding, used for percentage calculation.
2024-11-08Date of the company's N-CSR filing, disclosing shares outstanding.
2025-04-22Start date of the period for reported open market sales by Saba Capital.
2025-05-01Date of open market sale of 52,504 shares at $11.44.
2025-05-02Date of event which required filing of this Schedule 13D/A; also the end date of the period for reported open market sales by Saba Capital.
2025-05-05Date of signature for the Schedule 13D/A filing.

Keywords

Nuveen New Jersey Quality Municipal Income Fund, Saba Capital Management, Schedule 13D/A, Beneficial Ownership, Common Shares, SEC Filing, Investment Fund, Municipal Income, Share Sales, Institutional Investor

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.